Skip to content
SEARCH icon
  • Trade Alerts
  • Investing
  • Market News
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Technology
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
Search

SEARCH FOR AN ARTICLE

  • Trade Alerts
  • Investing
  • Market News
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Technology
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
icon

      Homeeditorial

      editorial

      Bilibili Inc. Announces Second Quarter 2026 Financial Results
      Technology

      Bilibili Inc. Announces Second Quarter 2026 Financial Results

      August 27, 2026
      CIBC Announces Third Quarter 2026 Results
      Financial

      CIBC Announces Third Quarter 2026 Results

      August 27, 2026
      CIBC Declares Dividends for the Quarter Ending October 31, 2026
      Financial

      CIBC Declares Dividends for the Quarter Ending October 31, 2026

      August 27, 2026
      CIBC to host Investor Day on December 9, 2026
      Financial

      CIBC to host Investor Day on December 9, 2026

      August 27, 2026
      Willis Lease Finance Corporation to Expand Global Maintenance Services with New Willis Engine Repair Center in Malaysia
      Financial

      Willis Lease Finance Corporation to Expand Global Maintenance Services with New Willis Engine Repair Center in Malaysia

      August 27, 2026
      AI is Directing People to the Least Accessible Pages on UK Websites, New AudioEye Study Finds
      Health

      AI is Directing People to the Least Accessible Pages on UK Websites, New AudioEye Study Finds

      August 27, 2026
      TEZSPIRE® DEMONSTRATES POSITIVE PHASE 3 RESULTS IN EOSINOPHILIC ESOPHAGITIS ACROSS BOTH CO-PRIMARY AND ALL KEY SECONDARY ENDPOINTS
      Biotech

      TEZSPIRE® DEMONSTRATES POSITIVE PHASE 3 RESULTS IN EOSINOPHILIC ESOPHAGITIS ACROSS BOTH CO-PRIMARY AND ALL KEY SECONDARY ENDPOINTS

      August 27, 2026
      AbbVie Submits Regulatory Application to EMA for SKYRIZI® (risankizumab) Subcutaneous Induction for Adults with Moderately to Severely Active Crohn’s Disease
      Biotech

      AbbVie Submits Regulatory Application to EMA for SKYRIZI® (risankizumab) Subcutaneous Induction for Adults with Moderately to Severely Active Crohn’s Disease

      August 27, 2026
      BranchOut Food Inc. Announces Proposed Public Offering
      Food & Beverage

      BranchOut Food Inc. Announces Proposed Public Offering

      August 27, 2026
      Rainier Acquisition Corporation Announces Pricing of $75,000,000 Initial Public Offering
      Financial

      Rainier Acquisition Corporation Announces Pricing of $75,000,000 Initial Public Offering

      August 27, 2026
      « 1 … 11 12 13 14 15 … 167 »

       

      LATEST NEWS

      • Investing Best Dividend Stock if the Bank of Canada Cuts Rates
      • Investing News Can This Undervalued Stock Make You a Millionaire?
      • Investing News High Dividend Yield Stocks for Passive Income: Fiera Capital
      • Investing Top Canadian ETFs to Buy and Hold in Your TFSA

      Trading Whisperer

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from Trading Whisperer.

      I want e-mail alerts, updates, and offers and agree to the Trading Whisperer privacy policy.

      Market Jar Media Inc. © 2026